Prokidney PROK
NASDAQ PROK
$1.71 +0.05 (+3.01%)
At close: Oct 1, 2026 · 4:00 PM EDT

Prokidney (PROK) Long-Term Investments (2021 - 2022)

Updated

Prokidney (PROK) reported Long-Term Investments of $250.37 million for Q2 2022, up 0.1% from the prior quarter.

Analysis

Prokidney (PROK) Long-Term Investments (2021 - 2022) Analysis & Trends

At the end of FY2021, Prokidney posted Long-Term Investments of $250.01 million.

  • Per Business Quant data, the three quarters before Q2 2022 came in at $250.03 million (Q1 2022), $250.01 million (Q4 2021) and $250 million (Q3 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Prokidney 848.66 Mn 1.96 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 250.37 Mn
Mar 31, 2022 250.03 Mn
Dec 31, 2021 250.01 Mn
Sep 30, 2021 250.00 Mn
API Access

Prokidney Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=PROK&period=max&api_key=YOUR_API_KEY